Market Research Industry Reports

Global Blood Glucose Monitoring Systems Market 2018-2024

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS

Global Blood Glucose Monitoring Systems Market – Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024

Overview:
Blood glucose monitoring is an integral part of the standard diabetes care, and it is very helpful in controlling the glucose levels in individuals with diabetes and impaired glucose tolerance. The incidence of diabetes is increasing globally, and around 90% of the patients have type 2 diabetes mellitus with approximately one-fifth of the people undergoing insulin treatment. Self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems are two major types of blood glucose monitoring systems.

The market for blood glucose monitoring systems is driven by increasing incidence of diabetes across various geographies, huge surge in the aging population, and increasing product launch and approvals. Increasing collaboration and funding to develop innovative devices and raising awareness among the patients are providing an opportunity for the market growth. Product recalls and inadequate reimbursements are few of the factors that may hamper the market growth to an extent.

Market Analysis:
The “Global Blood Glucose Monitoring Systems” market is estimated to witness a CAGR of 6.7% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, applications, end-users, and regions.

Regional Analysis:
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the major shareholder in the global blood glucose monitoring systems market, followed by Europe. The Asia Pacific region is expected to grow at a high CAGR during the forecast period due to an upsurge in access to health care services, increasing patient pool, raising awareness among patients, and growing healthcare expenditure. According to the Asian Diabetes Prevention Initiative, nearly 60% of the total diabetic population resides in Asia. It also estimates that 65.1 million adults in India and 113.9 million adults in China have diabetes.

Product Analysis:
The blood glucose monitoring systems market, by product, is segmented into self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems. SMBG systems occupied a significant market share in 2017, and CGM systems are expected to grow at a high CAGR during the forecast period. Increasing adoption of minimally invasive procedures makes it the fastest growing segment during the forecast period.

Application Analysis:
The market, by applications, is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes occupied a significant market share in 2017 and is expected to remain the same for the next 5 years. This is due to growing patient base for type 2 diabetes and increasing launch of the advanced product in this segment.

End-users Analysis:
The market, by end-users, is segmented into hospitals, homecare, private clinics, and others. Among various end-users, homecare occupied a significant market share and is expected to remain the same during the forecast period.

Key Players:
Medtronic plc, Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche Ltd., PHC Holdings Corporation, Ypsomed Holding, Dexcom, Acon Laboratories, Trividia Health Inc., Arkray Inc., Sanofi S.A., Terumo Medical Corporation, Prodigy Diabetes Care LLC, and niche players.

Competitive Analysis:
The market has a large number of medium and small players that offer innovative products and has immense growth opportunity, especially in the emerging countries. The key market players are taking advantage of product approvals and new product launches, making their strategies to increase the market share. For instance, in September 2017, the US FDA approved FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip. In February 2018, Roche Diabetes Care India announced the launch of its new glucometer Accu-Chek Instant S, which marks the entry of the organization into the mass market segment in diabetes self-monitoring.

Benefits:
The report provides complete details about the usage and adoption rate of blood glucose monitoring systems in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

1 Industry Outlook 8
1.1 Market Overview 8
1.2 Total addressable market 10
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 13
3 Market Snapshot 15
3.1 Market Definition – Infoholic Research 15
3.2 Advantages of blood glucose monitoring systems 15
3.3 Segmented Addressable Market (SAM) 15
3.4 Trends of the blood glucose monitoring systems market 15
3.5 Related Markets 17
3.5.1 Insulin pump 17
3.5.2 Smart insulin pen 17
3.5.3 Insulin Syringes 17
4 Market Outlook 18
4.1 Evolution of Blood Glucose Monitoring 18
4.2 Market segmentation 18
4.3 PEST Analysis 18
4.4 Porter 5(Five) Forces 19
5 Market Characteristics 21
5.1 DRO – Global Blood Glucose Monitoring Systems Market Dynamics 21
5.1.1 Drivers 21
5.1.1.1 Increasing incidence of diabetes across various geographies 21
5.1.1.2 Increasing number of product launch and approvals 22
5.1.1.3 Huge surge in the aging population 22
5.1.2 Opportunities 23
5.1.2.1 New collaboration and funding to develop new devices 23
5.1.2.2 Growing patient awareness 23
5.1.3 Restraints 24
5.1.3.1 High cost and inadequate reimbursement 24
5.1.3.2 Product recalls 24
5.2 DRO – Impact Analysis 24
5.3 Key Stakeholders 25
6 Products: Market Size & Analysis 27
6.1 Overview 27
6.2 Self-monitoring Blood Glucose Systems 28
6.3 Continuous Glucose Monitoring Systems 29
7 Application: Market Size & Analysis 31
7.1 Overview 31
7.2 Type 1 Diabetes 32
7.3 Type 2 Diabetes 32
7.4 Gestational Diabetes 33
8 End-User: Market Size & Analysis 34
8.1 Overview 34
8.2 Hospitals 35
8.3 Homecare 35
8.4 Private clinics 35
8.5 Others 36
9 Regions: Market Size and Analysis 37
9.1 Overview 37
9.2 North America 38
9.3 Europe 40
9.4 Asia Pacific 41
9.5 Rest of the World 43
10 Competitive Landscape 45
10.1 Overview 45
11 Vendor Profiles 48
11.1 Medtronic plc 48
11.1.1 Overview 48
11.1.2 Medtronic plc: Recent Developments 49
11.1.3 Business Units 56
11.1.4 Geographic Revenue 57
11.1.5 Business Focus 58
11.1.6 SWOT Analysis 58
11.1.7 Business Strategies 59
11.2 Abbott Laboratories 60
11.2.1 Overview 60
11.2.2 Abbott Laboratories: Recent Developments 61
11.2.3 Business Units 63
11.2.4 Geographic Presence 65
11.2.5 Business Focus 65
11.2.6 SWOT Analysis 66
11.2.7 Business Strategies 66
11.3 Johnson and Johnson 67
11.3.1 Overview 67
11.3.2 Business Units 71
11.3.3 Geographic Revenue 72
11.3.4 Business Focus 73
11.3.5 SWOT Analysis 74
11.3.6 Business Strategies 74
11.4 F.Hoffmann-La Roche Ltd. 75
11.4.1 Overview 75
11.4.2 Business Unit 78
11.4.3 Geographic Presence 78
11.4.4 Business Focus 79
11.4.5 SWOT Analysis 79
11.4.6 Business Strategy 80
12 Companies to Watch for 81
12.1 Dexcom 81
12.1.1 Overview 81
12.2 PHC Holdings Corporation 82
12.2.1 Overview 82
12.3 Ypsomed Holding 85
12.3.1 Overview 85
12.4 B. Braun Melsungen AG 86
12.4.1 Overview 86
12.5 Trividia Health, Inc. 88
12.5.1 Overview 88
12.6 Acon Laboratories 89
12.6.1 Overview 89
12.7 Sanofi S.A. 90
12.7.1 Overview 90
12.8 Arkray, Inc. 93
12.8.1 Overview 93
12.9 Nova Biomedical Corporation 94
12.9.1 Overview 94
12.10 Prodigy Diabetes Care, LLC 95
12.10.1 Overview 95
12.11 Terumo Medical Corporation 96
12.11.1 Overview 96


List Of Tables

TABLE 1 ESTIMATED PERCENTAGE INCREASE IN AGING POPULATION, 2015–2035 23
TABLE 2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS REVENUE BY REGIONS, 2017–2024 ($MILLION) 38
TABLE 3 OTHER VENDORS OF BLOOD GLUCOSE MONITORING SYSTEMS MARKET 47
TABLE 4 MEDTRONIC PLC: OFFERINGS 48
TABLE 5 ABBOTT LABORATORIES: PRODUCT OFFERINGS 60
TABLE 6 JOHNSON AND JOHNSON: OFFERINGS 67
TABLE 7 JOHNSON AND JOHNSON: RECENT DEVELOPMENTS 68
TABLE 8 F. HOFFMANN-LA ROCHE LTD.: OFFERINGS 75
TABLE 9 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 75
TABLE 10 DEXCOM, INC.: SNAPSHOT 81
TABLE 11 DEXCOM, INC.: RECENT DEVELOPMENTS 82
TABLE 12 PHC HOLDINGS CORPORATION: SNAPSHOT 83
TABLE 13 PHC HOLDINGS CORPORATION: RECENT DEVELOPMENTS 83
TABLE 14 YPSOMED HOLDINGS: SNAPSHOT 85
TABLE 15 YPSOMED HOLDING: RECENT DEVELOPMENTS 86
TABLE 16 B. BRAUN MELSUNGEN AG: SNAPSHOT 87
TABLE 17 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS 87
TABLE 18 TRIVIDIA HEALTH, INC.: SNAPSHOT 88
TABLE 19 TRIVIDIA HEALTH, INC.: RECENT DEVELOPMENTS 89
TABLE 20 ACON LABORATORIES: SNAPSHOT 89
TABLE 21 ACON LABORATORIES: RECENT DEVELOPMENTS 90
TABLE 22 SANOFI: SNAPSHOT 91
TABLE 23 SANOFI: RECENT DEVELOPMENTS 91
TABLE 24 ARKRAY, INC.: SNAPSHOT 93
TABLE 25 ARKRAY, INC.: RECENT DEVELOPMENTS 94
TABLE 26 NOVA BIOMEDICAL CORPORATION: SNAPSHOT 94
TABLE 27 NOVA BIOMEDICAL: RECENT DEVELOPMENTS 95
TABLE 28 PRODIGY DIABETES CARE: SNAPSHOT 96
TABLE 29 PRODIGY DIABETES CARE: RECENT DEVELOPMENTS 96
TABLE 30 TERUMO MEDICAL CORPORATION: SNAPSHOT 96
TABLE 31 TERUMO MEDICAL CORPORATION: RECENT DEVELOPMENTS 97

 


List Of Figures

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 8
CHART 2 DIABETES CARE DEVICES MARKET SEGMENTATION 11
CHART 3 RESEARCH METHODOLOGY OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 13
CHART 4 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE, 2017–2024 ($MILLION) 16
CHART 5 SEGMENTATION OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 18
CHART 6 PEST ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 18
CHART 7 PORTER 5 FORCES ON GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 19
CHART 8 DRO – IMPACT ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 24
CHART 9 KEY STAKEHOLDERS 25
CHART 10 GLOBAL BLOOD GLUCOSE MONITORING SYSTEM BY PRODUCT SEGMENTATION, 2017 (%) 27
CHART 11 GLOBAL SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017–2024 ($MILLION) 28
CHART 12 GLOBAL CONTINUOUS BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017–2024 ($MILLION) 30
CHART 13 GLOBAL BLOOD GLUCOSE MONITORING MARKET BY APPLICATION SEGMENTATION, 2017 (%) 31
CHART 14 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS BY END-USERS SEGMENTATION, 2017 (%) 34
CHART 15 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 37
CHART 16 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%) 38
CHART 17 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION) 39
CHART 18 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION) 41
CHART 19 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION) 43
CHART 20 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION) 44
CHART 21 MEDTRONIC PLC: OVERVIEW SNAPSHOT 56
CHART 22 MEDTRONIC PLC: BUSINESS UNITS 56
CHART 23 MEDTRONIC PLC: GEOGRAPHIC REVENUE 57
CHART 24 MEDTRONIC PLC: SWOT ANALYSIS 58
CHART 25 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 63
CHART 26 ABBOTT LABORATORIES: BUSINESS UNITS REVENUE 63
CHART 27 ABBOTT LABORATORIES: GEOGRAPHICAL PRESENCE 65
CHART 28 ABBOTT LABORATORIES: SWOT ANALYSIS 66
CHART 29 JOHNSON AND JOHNSON: OVERVIEW SNAPSHOT 70
CHART 30 JOHNSON & JOHNSON: BUSINESS UNITS 71
CHART 31 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 72
CHART 32 JOHNSON & JOHNSON: SWOT ANALYSIS 74
CHART 33 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT 77
CHART 34 F. HOFFMANN.LA ROCHE: BUSINESS UNITS 78
CHART 35 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE 78
CHART 36 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS 79


Global Cupric Sulfate Market Research Report 2018

Cupric Sulfate Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing on the

USD 2850View Report

Global Photocatalyst Anion Light Market Research Report 2018

Photocatalyst Anion Light Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing on

USD 2850View Report

Global Blood Sample Collection Needle Market Research Report 2018

Blood Sample Collection Needle Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing

USD 2850View Report

Global Blood Therapeutics Inc (GBT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The companys lead drug candidate

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2750
  • Site Licence    USD 3500
  • Global Licence    USD 4500
$ 2750

Reports Details

Published Date : Jun 2018
No. of Pages :100
Country :Global
Category :Medical Devices
Publisher :Infoholic Research
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube